Seaport Therapeutics, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NASDAQ
Seaport Therapeutics announced its second quarter 2026 financial results, detailing progress in its clinical trials for major depressive disorder and generalized anxiety disorder, alongside a robust cash position post-IPO.